Mytinib 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Mytinib 400 mg Tablet

Mytinib 400 mg Tablet

Mytinib 400 mg Tablet contains imatinib mesylate 400 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor group. It is used to treat certain blood cancers such as chronic myeloid leukemia and acute lymphoblastic leukemia, as well as gastrointestinal stromal tumors. The tablet is taken orally as prescribed by a qualified healthcare professional.

BUY NOW

Category

Imatinib works by blocking specific tyrosine kinases that contribute to the growth and survival of abnormal cancer cells. It may also be prescribed for certain other conditions, including dermatofibrosarcoma protuberans and selected myelodysplastic or myeloproliferative disorders. Regular monitoring of blood counts, liver function, and other clinical parameters may be required during treatment. The dose and duration are individualized according to the disease being treated and the patient’s response to therapy.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Marketer Mylan Pharmaceuticals Pvt Ltd – A Viatris Company

Product Also Known As

Mytinib 400 mg Tablet, Mytinib 400mg Tablet, Mytinib 400 Tablet, Imatinib 400 mg Tablet, Imatinib 400mg Tablet, Imatinib Mesylate 400 mg Tablet, Imatinib Anticancer Tablet